Evidence map›Paper›PMID 31657437›Full record

ReviewBiochemical Society transactions2019

How is the acyl chain composition of phosphoinositides created and does it matter?

David Barneda, Sabina Cosulich, Len Stephens, Phillip Hawkins

Open access · hybridAbstract readReview
In one paragraph

Review in Biochemical Society transactions, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Structure of an open KNature communications · 2024
    Article
  12. Reconstitution of ORP-mediated lipid exchange coupled to PI4P metabolism.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  13. Review
  14. Review
  15. SF-1 Induces Nuclear PIP2.Biomolecules · 2023
    Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 4 countries.

David BarnedaOncology R&D, AstraZeneca, Cambridge, U.K.
Sabina CosulichOncology R&D, AstraZeneca, Cambridge, U.K.
Len StephensSignalling Programme, Babraham Institute, Cambridge, U.K.
Phillip HawkinsSignalling Programme, Babraham Institute, Cambridge, U.K.
AstraZeneca (United Kingdom) · GBBabraham Institute · GB

Funding

Biotechnology and Biological Sciences Research Council BB/P013384/1Biotechnology and Biological Sciences Research Council BBS/E/B/000C0415
6 · The paper itself

Abstract

The phosphoinositide (PIPn) family of signalling phospholipids are central regulators in membrane cell biology. Their varied functions are based on the phosphorylation pattern of their inositol ring, which can be recognized by selective binding domains in their effector proteins and be modified by a series of specific PIPn kinases and phosphatases, which control their interconversion in a spatial and temporal manner. Yet, a unique feature of PIPns remains largely unexplored: their unusually uniform acyl chain composition. Indeed, while most phospholipids present a range of molecular species comprising acyl chains of diverse length and saturation, PIPns in several organisms and tissues show the predominance of a single hydrophobic backbone, which in mammals is composed of arachidonoyl and stearoyl chains. Despite evolution having favoured this specific PIPn configuration, little is known regarding the mechanisms and functions behind it. In this review, we explore the metabolic pathways that could control the acyl chain composition of PIPns as well as the potential roles of this selective enrichment. While our understanding of this phenomenon has been constrained largely by the technical limitations in the methods traditionally employed in the PIPn field, we believe that the latest developments in PIPn analysis should shed light onto this old question.

Indexed as

1-Phosphatidylinositol 4-KinaseAnimalsBinding SitesPhosphatidylinositolsSignal Transduction1-Phosphatidylinositol 4-KinasePhosphatidylinositolslipid-binding domainslipid metabolismmembranesphosphatidylinositolpolyunsaturated fatty acidssignalling

Identifiers

PMID31657437
PMCPMC6824679
OpenAlexW2981565897

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.